Assessment of disease treatment
AssigneeAIQ Solutions
InventorsRobert JERAJ, Timothy PERK, Stephen YIP, S. Sean HOUSHMANDI
Life of this patent
Estimating the term…
Abstract
The present disclosure provides methods, systems, and non-transitory computer-readable media for assessment of disease treatment or progression on a lesion-by-lesion level. The systems and methods are based on measurements of a variety of features including total number of lesions, total number and proportion of lesions regressing or progressing, changes in dimensions of a lesion over time, and uptake values of a molecular imaging agent.
Claims29
A method of assessing treatment and progression of a disease in a subject comprising:
- acquiring a first imaging scan of the subject wherein the imaging scan is configured to identify and segment lesions in the subject;
- processing the scan to:
- identify locations of the lesions,
- quantify the lesions in the subject, and
- calculate an imaging signal for at least one imaging feature of each lesion;
- and
- providing a disease treatment assessment score based on evaluation of the imaging signal for features directed to individual lesions, for features that consider differences in imaging signals across any combination or all lesions in the subject, or a combination thereof.
3-5. (canceled)
(canceled)
(canceled)
15-16. (canceled)
(canceled)
23-24. (canceled)
(canceled)
(canceled)
A non-transitory computer-readable medium storing instructions, that when executed by one or more processors performs operations comprising:
- receiving a first imaging scan of a subject and related scan and subject demographics, wherein the imaging scan is configured to identify and segment lesions in the subject;
- processing the first scan to identify locations of the lesions, quantify the total number of lesions, and calculate an imaging signal for at least one imaging feature of each lesion;
- evaluating the imaging signals for features directed to individual lesions, for features that consider differences in imaging signals across any combination or all lesions in the subject, or a combination thereof;
- providing a disease treatment assessment score;
- and
- optionally, one or more of:
- a) receiving an anatomical scan;
- classifying the lesions according to anatomical location;
- and
- evaluating individual lesions in a subset of anatomical locations of the subject;
- b) receiving at least one additional imaging scan and related scan and subject demographics, wherein the at least one imaging scan is configured to identify and segment lesions;
- processing the at least one additional imaging scan to identify locations of the lesions, quantify the total number of lesions, and calculate an imaging signal for at least one imaging feature of each lesion;
- determining homologous lesion location between any two imaging scans;
- and
- measuring a change in each corresponding imaging signal;
- c) receiving a radiometric scan;
- extracting radiomic features from any or all of the radiometric scans;
- and
- evaluating changes in at least one radiomic feature to classify lesions as progressing or responding,
- wherein the disease treatment assessment score is further based on radiomic features;
- d) receiving disease-related biomarker data, wherein the disease treatment assessment score is further based on the disease-related biomarker data;
- and
- e) removing a specific lesion, or combination of lesions, or altering one or more imaging features representing successful treatment of a specific lesion, or combination of lesions, from a previous imaging scan;
- and
- providing a disease projection analysis.
33-58. (canceled)
Dependencies are inferred from the claim text.